American Airlines(AAL) stock is up more than 10% in early afternoon trading. The company expects to report its first pretax quarterly profit since the start of the pandemic. AAL stock reflects growing enthusiasm, although investors should consider the quality of earnings. Source: GagliardiPhotography / Shutterstock.comFew other industries have suffered as catastrophic of a collapse as air travel. That makes the recent news forAmerican Airlines(NASDAQ:AAL) stock that much sweeter. For the upcoming second quarter, management expects to post itsfirst pretax profitsince the start of the pandemic. Robust demand has bolstered the airline industry, leading to AAL stock gaining nearly 10% so far today.Like AAL, analysts expect many major U.S. airlines to post some of their strongest earnings since

Singapore Airlines stock price: what’s the latest?Singapore Airlines and Scoot, the two airlines in the SIA Group, carried a total of 1.45 million passengers in May 2022, up 62.7% from the previous month.Group passenger capacity (measured in available seat-kilometres) reached 57% of pre-Covid-19 levels in May 2022, six percentage points above the month before.The passenger load factor for the month stood at 72.7%, which is the highest since the onset of the pandemic, the group said. This was an improvement of 18.2 percentage points month-on-month or 59 percentage points year-on-year.The blue-chip counter, which has an average price target of S$5.Why did DBS rate SIA a ‘buy’?Earlier that same day, DBS analysts also published their latest investment analysis on the SIA stock, in which they l

Ascendas REIT stock price: The blue-chip counter, which has an average price target of S$3.307 and rating of ‘outperform’ (based on SGX StockFacts data) is also down 7% year-to-date.OCBC analysts provided the latest price estimate and thesis on AREIT. They lowered their price target on the stock to S$3.43 from S$3.84 previously, but maintained a ‘buy’ rating.What about the proposed acquisitions?On Monday (09 May 2022), Ascendas Funds Management (S) Limited, the manager of AREIT, announced the proposed acquisition of a portfolio of seven logistics properties located across Chicago, Illinois, US, from BREIT Industrial HS Property Owner LLC, BREIT Industrial Canyon IL1M03 LLC, BCORE Jupiter NEMW 1 LLC and Icon Pac Owner Pool 4 Northeast/Midwest, LLC, third-party vendors.The seven target prope

Spero Therapeutics(SPRO) stock is getting a boost from U.S. Food and Drug Administration (FDA) news. That includes positive feedback for its complicated urinary tract infection (cUTI) treatment. The company is now planning an additional Phase 3 clinical trial of tebipenem HBr. Source: ShutterstockSpero Therapeutics(NASDAQ:SPRO) stock is climbing higher on Wednesdaythanks to positive feedbackfrom the U.S. Food and Drug Administration (FDA).The news concerns plans for the company to resubmit tebipenem HBr for the treatment of complicated urinary tract infection (cUTI). During a Type A meeting, the FDA said “positive results from an additional Phase 3 trial […] could be sufficient to support the approval of tebipenem HBr for cUTI.”It’s worth noting that Spero has already conducted a Phase 3 c